These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12540587)

  • 1. Influence of extracellular bactericidal agents on bacteria within macrophages.
    Hamrick TS; Diaz AH; Havell EA; Horton JR; Orndorff PE
    Infect Immun; 2003 Feb; 71(2):1016-9. PubMed ID: 12540587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host and bacterial factors involved in the innate ability of mouse macrophages to eliminate internalized unopsonized Escherichia coli.
    Hamrick TS; Havell EA; Horton JR; Orndorff PE
    Infect Immun; 2000 Jan; 68(1):125-32. PubMed ID: 10603378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of extracellular bacteria by antibiotics in quantitative assays of bacterial ingestion and killing by phagocytes.
    Tabrizi SN; Robins-Browne RM
    J Immunol Methods; 1993 Feb; 158(2):201-6. PubMed ID: 8429226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of aminoglycosides against phagocytosed bacteria.
    Utili R; Adinolfi LE; Dilillo M; Tripodi MF; Marrone A; Ruggiero G
    J Antimicrob Chemother; 1991 Dec; 28(6):897-904. PubMed ID: 1816186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased phagocytosis and killing of Escherichia coli treated with subinhibitory concentrations of cefamandole and gentamicin in isolated rat livers.
    Andreana A; Perna P; Utili R; Dilillo M; Ruggiero G
    Antimicrob Agents Chemother; 1984 Feb; 25(2):182-6. PubMed ID: 6370126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How type 1 fimbriae help Escherichia coli to evade extracellular antibiotics.
    Avalos Vizcarra I; Hosseini V; Kollmannsberger P; Meier S; Weber SS; Arnoldini M; Ackermann M; Vogel V
    Sci Rep; 2016 Jan; 6():18109. PubMed ID: 26728082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic.
    Baorto DM; Gao Z; Malaviya R; Dustin ML; van der Merwe A; Lublin DM; Abraham SN
    Nature; 1997 Oct; 389(6651):636-9. PubMed ID: 9335508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K88 Fimbrial Adhesin Targeting of Microspheres Containing Gentamicin Made with Albumin Glycated with Lactose.
    Sarabia-Sainz AI; Sarabia-Sainz HM; Montfort GR; Mata-Haro V; Guzman-Partida AM; Guzman R; Garcia-Soto M; Vazquez-Moreno L
    Int J Mol Sci; 2015 Sep; 16(9):22425-37. PubMed ID: 26389896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm formation by multidrug resistant Escherichia coli ST131 is dependent on type 1 fimbriae and assay conditions.
    Sarkar S; Vagenas D; Schembri MA; Totsika M
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of avian pathogenic Escherichia coli virulence factors in bacterial interaction with chicken heterophils and macrophages.
    Mellata M; Dho-Moulin M; Dozois CM; Curtiss R; Lehoux B; Fairbrother JM
    Infect Immun; 2003 Jan; 71(1):494-503. PubMed ID: 12496200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: FimH adhesin of type 1 fimbriae is a novel TLR4 ligand.
    Mossman KL; Mian MF; Lauzon NM; Gyles CL; Lichty B; Mackenzie R; Gill N; Ashkar AA
    J Immunol; 2008 Nov; 181(10):6702-6. PubMed ID: 18981086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Heptylmannoside-Based Glycoconjugate Antiadhesive Compounds against Adherent-Invasive Escherichia coli Bacteria Associated with Crohn's Disease.
    Sivignon A; Yan X; Alvarez Dorta D; Bonnet R; Bouckaert J; Fleury E; Bernard J; Gouin SG; Darfeuille-Michaud A; Barnich N
    mBio; 2015 Nov; 6(6):e01298-15. PubMed ID: 26578673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the responses of peritoneal macrophages from Japanese flounder (Paralichthys olivaceus) against high virulent and low virulent strains of Edwardsiella tarda.
    Ishibe K; Osatomi K; Hara K; Kanai K; Yamaguchi K; Oda T
    Fish Shellfish Immunol; 2008 Feb; 24(2):243-51. PubMed ID: 18178102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition profiles of mono- and polyvalent FimH antagonists against 10 different Escherichia coli strains.
    Chalopin T; Brissonnet Y; Sivignon A; Deniaud D; Cremet L; Barnich N; Bouckaert J; Gouin SG
    Org Biomol Chem; 2015 Dec; 13(46):11369-75. PubMed ID: 26440382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Tract Infection: Which Conformation of the Bacterial Lectin FimH Is Therapeutically Relevant?
    Mayer K; Eris D; Schwardt O; Sager CP; Rabbani S; Kleeb S; Ernst B
    J Med Chem; 2017 Jul; 60(13):5646-5662. PubMed ID: 28471659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific residues in the N-terminal domain of FimH stimulate type 1 fimbriae assembly in Escherichia coli following the initial binding of the adhesin to FimD usher.
    Munera D; Palomino C; Fernández LA
    Mol Microbiol; 2008 Aug; 69(4):911-25. PubMed ID: 18627459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
    Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation and targeting of E. coli internalized by endothelial cells using albumin microspheres loaded with gentamicin.
    Haswani DK; Nettey H; D'Souza MJ; Oettinger CW
    Drug Dev Ind Pharm; 2007 Feb; 33(2):181-90. PubMed ID: 17454050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H
    Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.